Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities

Esposito, Roberta; Ullrich, Sebastian, 1984-; Johnson, Rory

doi:http://dx.doi.org/10.1016/j.xgen.2022.100171

Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities

License

Citation

Esposito R, Polidori T, Meise DF, Pulido-Quetglas C, Chouvardas P, Forster S et al. Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities. Cell Genomics. 2022;2(9):100171. DOI: 10.1016/j.xgen.2022.100171

Abstract

Long noncoding RNAs (lncRNAs) are widely dysregulated in cancer, yet their functional roles in cancer hallmarks remain unclear. We employ pooled CRISPR deletion to perturb 831 lncRNAs detected in KRAS-mutant non-small cell lung cancer (NSCLC) and measure their contribution to proliferation, chemoresistance, and migration across two cell backgrounds. Integrative analysis of these data outperforms conventional “dropout” screens in identifying cancer genes while prioritizing disease-relevant lncRNAs with pleiotropic and background-independent roles. Altogether, 80 high-confidence oncogenic lncRNAs are active in NSCLC, which tend to be amplified and overexpressed in tumors. A follow-up antisense oligonucleotide (ASO) screen shortlisted two candidates, Cancer Hallmarks in Lung LncRNA 1 (CHiLL1) and GCAWKR, whose knockdown consistently suppressed cancer hallmarks in two- and three-dimension tumor models. Molecular phenotyping reveals that CHiLL1 and GCAWKR control cellular-level phenotypes via distinct transcriptional networks. This work reveals a multi-dimensional functional lncRNA landscape underlying NSCLC that contains potential therapeutic vulnerabilities.